Genetic Variation of Human UDP-Glucuronosyltransferase: Implications in Disease and Drug Glucuronidation

Author： Burchell B.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.1, 2003-01, pp. : 37-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver

By Mano Yuji   Usui Takashi   Kamimura Hidetaka  

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1502-1508

Springer Publishing Company

Access to resources Recommend Favorite

Polymorphism of UDP-Glucuronosyltransferase and Drug Metabolism

By  

Current Drug Metabolism, Vol. 6, Iss. 2, 2005-04 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Human UDP-Glucuronosyltransferase 2B7

By  

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 283-298

Bentham Science Publishers

Access to resources Recommend Favorite

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

By Miners John O.   Mackenzie Peter I.   Knights Kathleen M.  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 196-208

Informa Healthcare

Access to resources Recommend Favorite

Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term

By Reimers Arne  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 35, Iss. 3-4, 2011-01 ,pp. : 79-82

Springer Publishing Company

Access to resources Recommend Favorite